Foresite Capital

Activity in this selectionhbm-healthcare-bb732a39

By stage

Series C+4

Series A2

Series B1

Biotech5

Healthtech2

United States7

7 in this selection

Aug 18

Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases

$66MSeries D

Role not disclosed

Aug 13

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B

Role not disclosed

Jun 8

Offers accelerated, affordable training for healthcare careers

$55MSeries C

Role not disclosed

Feb 24

Advancing next-generation therapeutics for migraine and other headache disorders

$130MSeries A

Role not disclosed

Feb 18

Develops novel therapies to reduce the burden of neurodegenerative diseases

$175MSeries A

Role not disclosed

Feb 3

Provides accessible, insurance-covered services in all 50 states for women's healthcare

$100MSeries D

Role not disclosed